A comprehensive view of Inflammations. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Pet Care Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Novartis acquires IFM Therapeutics subsidiary IFM Due for US$90.0M upfront, plus potential milestones totaling US$835.0M; Novartis gets full rights to the STING antagonist program developed in a four-year research collaboration

New findings in food allergies reveal the immunomodulatory role of milk-derived bioactive peptides; the study highlights the potential health benefits of these peptides in regulating inflammatory balance in food allergy: Nanchang University, China

Sun Pharma's US branch recalls 55,272 bottles of febuxostat gout tablets due to microbial contamination at its Dadra, India, manufacturing facility; recall covers 40-milligram and 80-milligram dosages

FDA approves Fresenius Kabi's Tyenne, a biosimilar tocilizumab drug for inflammatory and immune diseases referencing Actemra tocilizumab in both IV and subcutaneous formulations; this marks the company's third biosimilar approval in the US

Almirall acquires global rights to develop and market Novo Nordisk's IL-21 blocking monoclonal antibody, NN-8828, for immune inflammatory dermatological diseases; Almirall to explore the new approach of IL-21 blockage as a treatment for skin disorders

Ask us about our Pet Care market view

Trending Chart

Interactive chart with headline count